FOCUS DIAGNOSTICS -- FIRST U.S. LABORATORY TO LICENSE NEWLY DISCOVERED CORONAVIRUS CoV-NL63 FROM PRIMAGEN

Today Focus Diagnostics, Inc. announced a license agreement with Primagen Holding, B.V., to develop PCR detection for human coronavirus NL63, a newly identified virus related to SARS and other coronaviruses. The new coronavirus causes severe respiratory disease in children under 5 and is associated with respiratory disease in adults and the elderly. The agreement will allow Focus Diagnostics' infectious disease reference laboratory in Cypress, CA, to be the first U.S. laboratory to bring to market a test for this new infectious agent.

Yahoo News (http://biz.yahoo.com/prnews/050912/phm036.html?.v=21)